Physician profile
Timothy Blegen
NPI 1982997193
$1,944.67
in general payments reported to CMS, 2019-2025
18 companies · $274 in 2025
The $274 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2021: $238 · 2022: $741 · 2023: $279 · 2024: $240 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $793.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $793.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomerieux INC | $610.87 | 2022 | |
| Pfizer INC. | $333.05 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $231.15 | 2021-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $181.88 | 2021-2024 | |
| Kaleo, INC. | $108.39 | 2019-2023 | Auvi-Q |
| Sobi, INC | $91.91 | 2019-2021 | |
| Cranial Technologies, INC | $87.60 | 2019-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $52.59 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $45.46 | 2025 | Zoryve |
| Genzyme Corporation | $33.25 | 2023 | |
| Collegium Pharmaceutical, INC. | $29.35 | 2025 | Jornay Pm |
| Kyowa Kirin, INC. | $25.99 | 2025 | |
| Verrica Pharmaceuticals INC. | $25.00 | 2023 | Ycanth |
| Shire North American Group INC | $19.98 | 2019 | |
| Genentech USA, INC. | $18.77 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $18.19 | 2024 | Voxzogo 1.2mg |
| Ironshore Pharmaceuticals INC. | $16.73 | 2024 | |
| Alk-Abello, INC | $14.51 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Blegen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.